Cardioexplorer wins Swiss Biolabs Award 2018


Heart disease is the leading cause of death. So far there was no simple test for detection of life-threatening constrictions of the heart arteries. Cardioexplorer is a simple and non-invasive Artificial Intelligence based lab test which provides a safe risk assessment of current coronary heart disease. The test provides higher sensitivity / specificity than the stress ECG.

Out of seven finalists, Exploris has won the Swiss Biolabs Challenge 2018.The jury consisted of Universities (University Hospital Basel, School of Life sciences Biotechnet Switzerland), industry partners (Sensile Medical, Roche Diagnostics, Omya International AG, Ava Science, Bühlmann Laboratories) and  Associations (Swiss Biolabs Association, Economic Development Agency Olten, Basel Area).